| 51 | 15476902 | Role of aromatase inhibitors in the treatment of breast cancer. | Clin Ther | 2004 Aug |
1 |
| 52 | 15571956 | Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status. | Eur J Cancer | 2004 Dec |
1 |
| 53 | 15613451 | Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. | Endocr Relat Cancer | 2004 Dec |
2 |
| 54 | 15632249 | How rapidly do oncologists respond to clinical trial data? | Oncologist | 2005 Jan |
2 |
| 55 | 15645693 | An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys. | J Pediatr Endocrinol Metab | 2004 Dec |
2 |
| 56 | 15653211 | Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women. | Eur J Obstet Gynecol Reprod Biol | 2005 Feb 1 |
2 |
| 57 | 15681525 | Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. | J Clin Oncol | 2005 Feb 1 |
1 |
| 58 | 15719595 | Aromatase inhibitors in advanced breast cancer. | Semin Oncol | 2004 Dec |
1 |
| 59 | 15719596 | Aromatase inhibitors in early breast cancer therapy. | Semin Oncol | 2004 Dec |
1 |
| 60 | 15767642 | Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists. | J Clin Oncol | 2005 Apr 10 |
2 |
| 61 | 15788292 | Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer. | Acta Oncol | 2005 |
1 |
| 62 | 15814851 | Aromatase inhibitors in the treatment of breast cancer. | Endocr Rev | 2005 May |
1 |
| 63 | 15837728 | Aromatase inhibition: translation into a successful therapeutic approach. | Clin Cancer Res | 2005 Apr 15 |
1 |
| 64 | 15860267 | Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy. | J Steroid Biochem Mol Biol | 2005 Feb |
2 |
| 65 | 16030027 | Comparative effects of anastrozole, tamoxifen alone and in combination on plasma lipids and bone-derived resorption during neoadjuvant therapy in the impact trial. | Ann Oncol | 2005 Oct |
1 |
| 66 | 16034487 | Anastrozole. | Drugs Today (Barc) | 2005 Apr |
2 |
| 67 | 16054421 | New approaches to reverse resistance to hormonal therapy in human breast cancer. | Drug Resist Updat | 2005 Aug |
1 |
| 68 | 16234518 | Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status: an hypothesis-generating study. | J Clin Oncol | 2005 Oct 20 |
4 |
| 69 | 16263272 | Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen. | J Steroid Biochem Mol Biol | 2005 Dec |
1 |
| 70 | 16357134 | Aromatase inhibitors in human lung cancer therapy. | Cancer Res | 2005 Dec 15 |
4 |
| 71 | 16361981 | Testotoxicosis: current viewpoint. | Pediatr Endocrinol Rev | 2005 Dec |
1 |
| 72 | 16369246 | Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer. | MedGenMed | 2005 Aug 24 |
1 |
| 73 | 16423816 | Effects of decreased estradiol-17beta on the serum and anterior pituitary IGF-I system in pigs. | J Endocrinol | 2005 Dec |
3 |
| 74 | 16451067 | Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation. | J Med Chem | 2006 Feb 9 |
1 |
| 75 | 16467123 | Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial. | Clin Cancer Res | 2006 Feb 1 |
1 |
| 76 | 16847815 | Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients. | Int J Biol Markers | 2006 Apr-Jun |
1 |
| 77 | 16869719 | Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). | J Bone Miner Res | 2006 Aug |
2 |
| 78 | 16940812 | Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases. | Anticancer Drugs | 2006 Sep |
1 |
| 79 | 16950593 | Metastatic breast cancer: an updating. | Biomed Pharmacother | 2006 Nov |
1 |
| 80 | 17007849 | A prospective randomized trial comparing anastrozole and clomiphene citrate in an ovulation induction protocol using gonadotropins. | Fertil Steril | 2006 Dec |
1 |
| 81 | 17018237 | Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats. | Behav Brain Res | 2006 Dec 15 |
1 |
| 82 | 17079446 | Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor. | Cancer Res | 2006 Nov 1 |
1 |
| 83 | 17150002 | Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies. | Expert Opin Pharmacother | 2006 Dec |
1 |
| 84 | 17356042 | Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. | J Clin Endocrinol Metab | 2007 Jun |
2 |
| 85 | 17452676 | Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. | J Clin Oncol | 2007 May 20 |
2 |
| 86 | 17563395 | Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study. | J Clin Oncol | 2007 Jul 1 |
1 |
| 87 | 17618847 | Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. | Bone | 2007 Sep |
3 |
| 88 | 17693420 | The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors. | Ann Oncol | 2008 Jan |
1 |
| 89 | 17904790 | Aromatase inhibitor and bone. | Biomed Pharmacother | 2007 Oct |
2 |
| 90 | 18075758 | Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial. | J Cancer Res Clin Oncol | 2008 Jun |
4 |
| 91 | 18165285 | Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. | J Clin Endocrinol Metab | 2008 Mar |
1 |
| 92 | 18227529 | Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. | J Clin Oncol | 2008 Mar 1 |
4 |
| 93 | 18438705 | A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women. | Breast Cancer Res Treat | 2009 Apr |
4 |
| 94 | 18451180 | Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model. | Cancer Res | 2008 May 1 |
5 |
| 95 | 18451229 | The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer. | Clin Cancer Res | 2008 May 1 |
4 |
| 96 | 18490163 | Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence? | Breast | 2008 Aug |
1 |
| 97 | 18547136 | Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer. | Drugs | 2008 |
4 |
| 98 | 19250201 | Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators. | Ann N Y Acad Sci | 2009 Feb |
2 |
| 99 | 19261371 | Combined down-regulation by aromatase inhibitor and GnRH-agonist in IVF patients with endometriomas-A pilot study. | Eur J Obstet Gynecol Reprod Biol | 2009 May |
1 |
| 100 | 19281057 | Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer. | Clin Interv Aging | 2008 |
1 |